Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.
 
> Endothelin-1 (1-31) (Human)

Endothelin-1 (1-31) (Human)

Imprimer Imprimer
Identifiez-vous

Référence 4360-s

Conditionnement : 0.1mg

Marque : Peptide Institute

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Endothelin-1 (1-31) (Human)

Code:
4360-s
Name:
Endothelin-1 (1-31) (Human)
Documents
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11)
(M.W. 3628.2) C162H236N38O47S5
Purity:
≧95.0% (HPLC)
View Analytical Data Sheet
Storage:
-20 ℃
Production:
Synthetic Product

Solubility: 0.1% AcOH (0.1 mM)

Category:
Biologically Active Peptides

reference

  1. A. Nakano, F. Kishi, K. Minami, H. Wakabayashi, Y. Nakaya, and H. Kido, J. Immunol., 159, 1987 (1997). (Original; New Endogenous Form)
  2. F. Kishi, K. Minami, N. Okishima, M. Murakami, S. Mori, M. Yano, Y. Niwa, Y. Nakaya, and H. Kido, Biochem. Biophys. Res. Commun., 248, 387 (1998). (Pharmacol.)
  3. M. Yoshizumi, D. Inui, N. Okishima, H. Houchi, K. Tsuchiya, H. Wakabayashi, H. Kido, and T. Tamaki, Eur. J. Pharmacol., 348, 305 (1998). (Pharmacol.)
  4. M. Yoshizumi, S. Kim, S. Kagami, A. Hamaguchi, K. Tsuchiya, H. Houchi, H. Iwao, H. Kido, and T. Tamaki, Br. J. Pharmacol., 125, 1019 (1998). (Pharmacol.)
  5. M. Yanagisawa and T. Masaki, Trends Pharmacol. Sci., 10, 374 (1989). (Review)
  6. T. Sakurai, M. Yanagisawa, and T. Masaki, Trends Pharmacol. Sci., 13, 103 (1992). (Review)
  7. A.F. James, Y. Urade, R.L. Webb, H. Karaki, I. Umemura, Y. Fujitani, K. Oda, T. Okada, R.W. Lappe, and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993). (Review)